Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuyoshi Yokoi

Showing results (21-30 of 258) with videos related to

Pageof 26
Sort By:
Cancer Letters|August 23, 2005
Cytochrome P450-mediated metabolism of estrogens and its regulation in humanYuki Tsuchiya, Miki Nakajima, Tsuyoshi Yokoi
Toxicology|August 16, 2020
Pharmacological evidence for the involvement of ryanodine receptors in halothane-induced liver injury in miceRu Jia, Shingo Oda, Tsuyoshi Yokoi
Annual Review of Pharmacology and Toxicology|September 9, 2021
Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and DevelopmentTatsuki Fukami, Tsuyoshi Yokoi, Miki Nakajima
Journal of Applied Toxicology : JAT|October 17, 2018
Strain and interindividual differences in lamotrigine-induced liver injury in miceSho Akai, Shingo Oda, Tsuyoshi Yokoi
Journal of Applied Toxicology : JAT|December 8, 2015
Allopurinol induces innate immune responses through mitogen-activated protein kinase signaling pathways in HL-60 cellsAkira Nakajima, Shingo Oda, Tsuyoshi Yokoi
Frontiers in Pharmacology|November 9, 2016
Structure and Protein-Protein Interactions of Human UDP-GlucuronosyltransferasesRyoichi Fujiwara, Tsuyoshi Yokoi, Miki Nakajima
Drug Metabolism and Pharmacokinetics|October 23, 2004
Tissue-specific mRNA expression profiles of human nuclear receptor subfamiliesMasuhiro Nishimura, Shinsaku Naito, Tsuyoshi Yokoi
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metaboliteMiki Katoh, Tomohito Matsui, Tsuyoshi Yokoi
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 7, 2018
Cell-based assay using glutathione-depleted HepaRG and HepG2 human liver cells for predicting drug-induced liver injuryJieyu Xu, Shingo Oda, Tsuyoshi Yokoi
Biochemical Pharmacology|July 12, 2002
Identification of catalase in human livers as a factor that enhances phenytoin dihydroxy metabolite formation by human liver microsomesTomoko Komatsu, Hiroshi Yamazaki, Miki Nakajima, et al.
Pageof 26

Showing results (21-30 of 258) with videos related to

Sort By:
Pageof 26
Cancer Letters|August 23, 2005
Cytochrome P450-mediated metabolism of estrogens and its regulation in humanYuki Tsuchiya, Miki Nakajima, Tsuyoshi Yokoi
Toxicology|August 16, 2020
Pharmacological evidence for the involvement of ryanodine receptors in halothane-induced liver injury in miceRu Jia, Shingo Oda, Tsuyoshi Yokoi
Annual Review of Pharmacology and Toxicology|September 9, 2021
Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and DevelopmentTatsuki Fukami, Tsuyoshi Yokoi, Miki Nakajima
Journal of Applied Toxicology : JAT|October 17, 2018
Strain and interindividual differences in lamotrigine-induced liver injury in miceSho Akai, Shingo Oda, Tsuyoshi Yokoi
Journal of Applied Toxicology : JAT|December 8, 2015
Allopurinol induces innate immune responses through mitogen-activated protein kinase signaling pathways in HL-60 cellsAkira Nakajima, Shingo Oda, Tsuyoshi Yokoi
Frontiers in Pharmacology|November 9, 2016
Structure and Protein-Protein Interactions of Human UDP-GlucuronosyltransferasesRyoichi Fujiwara, Tsuyoshi Yokoi, Miki Nakajima
Drug Metabolism and Pharmacokinetics|October 23, 2004
Tissue-specific mRNA expression profiles of human nuclear receptor subfamiliesMasuhiro Nishimura, Shinsaku Naito, Tsuyoshi Yokoi
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metaboliteMiki Katoh, Tomohito Matsui, Tsuyoshi Yokoi
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 7, 2018
Cell-based assay using glutathione-depleted HepaRG and HepG2 human liver cells for predicting drug-induced liver injuryJieyu Xu, Shingo Oda, Tsuyoshi Yokoi
Biochemical Pharmacology|July 12, 2002
Identification of catalase in human livers as a factor that enhances phenytoin dihydroxy metabolite formation by human liver microsomesTomoko Komatsu, Hiroshi Yamazaki, Miki Nakajima, et al.
Pageof 26